Cargando…

Growth inhibitory effects of interferon on blast cells from patients with acute myelogenous leukaemia.

Detalles Bibliográficos
Autor principal:	Rohatiner, A. Z.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1984
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976834/ https://www.ncbi.nlm.nih.gov/pubmed/6587902

Ejemplares similares

Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia
por: Dalley, C D, et al.
Publicado: (2001)

Immunotherapy for Acute Myelogenous Leukaemia
por: Powles, R. L., et al.
Publicado: (1973)

Myelogenic Leukaemia
Publicado: (1915)

Cytotoxic effects of tumour necrosis factor and gamma-interferon on acute myeloid leukaemia blasts.
por: Price, G., et al.
Publicado: (1987)

Myelogenous Leukæmia and Its Treatment
por: Debove,
Publicado: (1910)

Further evidence of response by leukaemia patients in remission to antigen(s) related to acute myelogenous leukaemia.
por: Cocks, P., et al.
Publicado: (1977)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

Factors influencing prognosis in adults with acute myelogenous leukaemia.
por: Crowther, D., et al.
Publicado: (1975)

In vitro sensitivity of clonogenic cells in resisting and relapsing patients with acute myelogenous leukaemia.
por: Marie, J. P., et al.
Publicado: (1988)

Cytogenetic analysis of leukaemic colonies from acute and chronic myelogenous leukaemia.
por: Trent, J. M., et al.
Publicado: (1983)

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia.
por: Zuhrie, S. R., et al.
Publicado: (1980)

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
por: Hu, C. W., et al.
Publicado: (2019)

ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia
por: Perrotti, D, et al.
Publicado: (2006)

Sensitivity of normal and acute myelogenous leukaemia marrow cells to inhibition by cytosine arabinoside.
por: Potter, C. G., et al.
Publicado: (1980)

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia
por: Lee, C-Y, et al.
Publicado: (2007)

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
por: Sedlmayr, P., et al.
Publicado: (1992)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Unusual T-Lymphoblastic Blast Phase of Chronic Myelogenous Leukemia
por: Xu, Jie, et al.
Publicado: (2014)

Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia
por: Bhattacharya, Jenna B, et al.
Publicado: (2017)

Early central nervous system involvement in adults with acute non-myelogenous leukaemia.
por: Lister, T. A., et al.
Publicado: (1977)

Partial characterization of a membrane antigen which exhibits specificity for cells of patients with acute myelogenous leukaemia.
por: Shipman, R., et al.
Publicado: (1983)

Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation()
por: Tsukamoto, Shokichi, et al.
Publicado: (2013)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

Focal blast crisis in concomitant myelodysplastic syndrome and chronic myelogenous leukemia
por: Reap, Leo, et al.
Publicado: (2020)

Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India
por: Anand, Maninder Singh, et al.
Publicado: (2012)

Familial platelet disorders with a predisposition to acute myelogenous leukaemia: a RUNX1 update
por: Rossini, J, et al.
Publicado: (2012)

Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents
por: Ding, Yahui, et al.
Publicado: (2018)

Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
por: Cowan-Jacob, Sandra W., et al.
Publicado: (2006)

Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
por: Zhu, Y. M., et al.
Publicado: (1993)

Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature
por: Nagamos, Rochelle Nagales, et al.
Publicado: (2016)

Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia
por: Vráblová, Lucia, et al.
Publicado: (2023)

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia.
por: Rohatiner, A. Z., et al.
Publicado: (1990)

OGG1 rs1052133 Polymorphism and Genetic Susceptibility to Chronic Myelogenous Leukaemia
por: Hassan, Fathelrahman M
Publicado: (2019)

Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor
por: Corrado, Chiara, et al.
Publicado: (2016)

Blast phase transformation of chronic myelogenous leukemia presenting with central nervous system manifestation
por: Chikkannaiah, Panduranga, et al.
Publicado: (2016)

The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells
por: Naka, Kazuhito, et al.
Publicado: (2020)

Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
por: Schöttker, Björn, et al.
Publicado: (2011)

Heralding Extramedullary Blast Crisis: Horner's Syndrome with Brachial Plexopathy in a Patient with Chronic Myelogenous Leukemia
por: Jacob, Sajish, et al.
Publicado: (2016)

Kinetics of versican-expressing macrophages in bone marrow after cord blood stem cell transplantation for treatment of acute myelogenous leukaemia
por: Senda, Miho, et al.
Publicado: (2016)

Prognostic relevance of pretreatment proliferative rapidity of marrow blast cells in childhood acute lymphoblastic leukaemia.
por: Trerè, D., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_td7o2inuk20jpoapvrsm1ei0kd